MedSphere Corp Revenue and Competitors
Estimated Revenue & Valuation
- MedSphere Corp's estimated annual revenue is currently $6M per year.
- MedSphere Corp's estimated revenue per employee is $201,000
Employee Data
- MedSphere Corp has 30 Employees.
- MedSphere Corp grew their employee count by -35% last year.
MedSphere Corp's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director - Consulting Services & Business Development | Reveal Email/Phone |
2 | Accounts Payable Manager | Reveal Email/Phone |
3 | Researcher_ Women''s Health | Reveal Email/Phone |
MedSphere Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 119 | 13% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is MedSphere Corp?
A long-standing global Healthcare and Life Sciences research and consulting firm, offering a customizable, fully integrated suite of strategy, competitive, and market intelligence solutions, focused on creating competitive advantage, meeting the needs of our clients, and enhancing your capabilities to win in the evolving market place. Our heritage in the Biopharmaceutical domain remains our foundation, while earning the privilege of collaborating with Medical Device, Insurance, Payers, Distribution Channels, Genomic Testing and Laboratory firms.
keywords:N/AN/A
Total Funding
30
Number of Employees
$6M
Revenue (est)
-35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5M | 30 | -3% | N/A |
#2 | $3.8M | 32 | -11% | N/A |
#3 | $6.9M | 32 | -6% | N/A |
#4 | $5.4M | 33 | 6% | N/A |
#5 | N/A | 33 | 6% | N/A |